# Gene Chip Market > Gene Chip Market Research Report By Product Type (DNA Microarrays, RNA Microarrays, Protein Microarrays, Other Microarrays), By Application (Medical Diagnostics, Pharmaceutical Research, Academic Research, Agricultural Research, Other Applications), By End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutions, Clinical Laboratories, Hospitals and Clinics, Government Agencies) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 7.17% - **2024:** $ 1.97 Billion - **2025:** $ 2.11 Billion - **2035:** $ 4.22 Billion - **Key Players:** Affymetrix (US), Illumina (US), Thermo Fisher Scientific (US), Agilent Technologies (US), Roche (CH), Bio-Rad Laboratories (US), Qiagen (DE), PerkinElmer (US), Arrayit Corporation (US) **Report ID:** MRFR/LS/27837-HCR · **Pages:** 128 · **Author:** Rahul Gotadki · **Last Updated:** April 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/gene-chip-market-29562 --- ## Market Summary ## **Gene Chip Market Overview** As per MRFR analysis, the Gene Chip Market Size was estimated at 1.97 (USD Billion) in 2024. The Gene Chip Market Industry is expected to grow from 2.11 (USD Billion) in 2025 to 3.94 (USD Billion) till 2034, at a CAGR (growth rate) is expected to be around 7.17% during the forecast period (2025 - 2034). ## **Gene Chip Market Drivers** ### Advancements in Gene Editing and Sequencing Techniques The rapid advancements in gene editing and sequencing technologies have significantly contributed to the growth of the Gene Chip Market. The advent of techniques such as CRISPR-Cas9 and next-generation sequencing (NGS) has revolutionized the field of genomics, enabling researchers to precisely modify and analyze genetic material. These advancements have led to a surge in demand for Gene Chips, which play a crucial role in gene expression analysis and biomarker discovery. The integration of gene editing and sequencing technologies with Gene Chips provides researchers with powerful tools to investigate genetic disorders, develop personalized therapies, and gain a deeper understanding of biological processes. ### Growing Prevalence of Genetic Disorders and Personalized Medicine The increasing prevalence of genetic disorders worldwide is another key driver of the Gene Chip Market. Genetic disorders, such as cancer, cardiovascular diseases, and neurological disorders, affect millions of individuals globally. Gene Chips enable researchers and clinicians to identify genetic variations associated with these disorders, leading to improved diagnosis, risk assessment, and targeted therapies. Personalized medicine is gaining traction as a promising approach to healthcare, with Gene Chips playing a vital role in tailoring treatments to individual genetic profiles. By analyzing gene expression patterns, Gene Chips provide valuable insights into disease susceptibility, drug response, and potential treatment options. ### Increased Research Funding and Government Initiatives Government initiatives and increased research funding have played a significant role in driving the growth of the Gene Chip Market. Many governments worldwide have recognized the importance of genomics research and have allocated substantial funding to support projects involving Gene Chips. These initiatives aim to advance our understanding of genetic diseases, develop novel therapies, and improve healthcare outcomes. Additionally, collaborations between academia and industry have fostered innovation and accelerated the development of Gene Chip technologies. The availability of research grants and funding opportunities has attracted researchers to the field, further contributing to the growth of the Gene Chip Market. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ## **Gene Chip Market Segment Insights** ### **Gene Chip Market Product Type Insights** Among these, the DNA Microarrays segment held the largest market share in 2023 and is expected to continue its dominance throughout the forecast period. DNA Microarrays are widely used in various research applications, including gene expression profiling, genotyping, and biomarker discovery, owing to their ability to analyze large numbers of genes simultaneously. The RNA Microarrays segment is anticipated to register a significant CAGR during the forecast period. RNA Microarrays are becoming increasingly popular for studying gene expression patterns and identifying differentially expressed genes in different biological samples. This growth can be attributed to the increasing demand for RNA-based technologies in fields such as transcriptomics and RNA sequencing. Protein Microarrays, on the other hand, are gaining traction in proteomics research. They enable the detection and quantification of multiple proteins simultaneously, providing valuable insights into protein expression profiles and protein-protein interactions. The Other Microarrays segment includes various specialized microarray types, such as tissue microarrays and cell microarrays. These microarrays are used in applications such as immunohistochemistry, tissue profiling, and cell-based assays. The growth of the Gene Chip Market is driven by factors such as the rising prevalence of chronic diseases, increasing adoption of personalized medicine, and advancements in genomic technologies. The market is also benefiting from government initiatives and funding for genomics research projects. However, factors such as high costs associated with microarray experiments and regulatory hurdles may restrain market growth to some extent. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ### **Gene Chip Market Application Insights** The Gene Chip Market is segmented into various applications, including Medical Diagnostics, Pharmaceutical Research, Academic Research, Agricultural Research, and Other Applications. Medical Diagnostics accounted for the largest share of the market in 2023, owing to the increasing demand for personalized medicine and the rising prevalence of chronic diseases. Pharmaceutical Research is also a major application, with Gene Chip technology being used for drug discovery and development. Academic Research and Agricultural Research are other important applications, driven by the need for genetic research and crop improvement, respectively. Other Applications include environmental monitoring, forensic analysis, and biotechnology research. ### **Gene Chip Market End User Insights** The End User segment of the Gene Chip Market encompasses a diverse range of entities that utilize Gene Chip technology for various purposes. Pharmaceutical and biotechnology companies leverage Gene Chips for drug discovery, target identification, and personalized medicine development. Academic and research institutions employ Gene Chips in genetic research, disease diagnostics, and biomarker discovery. Clinical laboratories leverage Gene Chips for genetic testing, infectious disease detection, and personalized treatment planning. Hospitals and clinics utilize Gene Chips for patient diagnosis, prognosis prediction, and treatment selection. Government agencies employ Gene Chips for public health initiatives, disease surveillance, and regulatory purposes. In 2023, the Pharmaceutical and Biotechnology Companies segment accounted for the largest share of the Gene Chip Market revenue, followed by Academic and Research Institutions. The Clinical Laboratories segment is projected to witness the highest growth rate during the forecast period. ### **Gene Chip Market Regional Insights** The regional segmentation of the Gene Chip Market offers insights into the market's geographic distribution and growth patterns. North America is anticipated to dominate the market in 2024, with a significant share of the Gene Chip Market revenue. The region's well-established healthcare infrastructure, high disposable income, and increasing prevalence of genetic disorders contribute to its dominance. Europe follows closely behind North America, driven by government initiatives and advancements in healthcare technology. The Asia-Pacific (APAC) region is projected to experience robust growth, owing to rising healthcare expenditure, growing awareness of genetic testing, and increasing investments in healthcare infrastructure. South America and the Middle East and Africa (MEA) regions are expected to witness a steady growth trajectory, as these regions continue to develop their healthcare systems and invest in genetic research. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ### **Gene Chip Market Key Players and Competitive Insights** Major players in the Gene Chip Market are constantly engaging in strategic collaborations, acquisitions, and partnerships to expand their market presence and strengthen their competitive position. Leading Gene Chip Market players are investing heavily in research and development activities to introduce technologically advanced products and solutions. The Gene Chip Market is expected to witness significant growth in the coming years, driven by the increasing demand for personalized medicine, advancements in genomics technologies, and the rising prevalence of chronic diseases. The competitive landscape of the Gene Chip Market is characterized by a mix of established and emerging players, each with their unique strengths and focus areas. Among the leading players in the Gene Chip Market, Thermo Fisher Scientific holds a dominant position with a comprehensive portfolio of products and services. The company offers a wide range of gene chips for various applications, including gene expression analysis, genotyping, and copy number variation analysis. Thermo Fisher Scientific also provides supporting instruments, software, and reagents, enabling end-to-end solutions for gene chip-based research. Another major player in the Gene Chip Market is Illumina, Inc., known for its innovative sequencing technologies. Illumina offers a range of gene chips designed for applications such as targeted sequencing, whole-genome sequencing, and single-cell analysis. The company's focus on developing high-throughput and cost-effective sequencing solutions has contributed to its strong position in the market. A notable competitor in the Gene Chip Market is Affymetrix, Inc., a subsidiary of Thermo Fisher Scientific. Affymetrix offers a portfolio of gene chips for gene expression analysis and genotyping. The company's gene chips are known for their high sensitivity and specificity, making them well-suited for applications in clinical diagnostics and research. Affymetrix also provides a range of supporting software and services, enabling comprehensive data analysis and interpretation. ## **Key Companies in the Gene Chip Market Include** ## **Gene Chip Market Developments** The increasing adoption of Gene Chip technology in personalized medicine, drug discovery, and genetic research drives market growth. Key industry developments include Illumina's launch of the NovaSeq X Series, offering faster sequencing speeds, and Thermo Fisher Scientific's acquisition of Affymetrix, expanding its portfolio of Gene Chip solutions. Growing government funding for genomics research and the rising prevalence of chronic diseases further contribute to market expansion. ## **Gene Chip Market Segmentation Insights** ### **Gene Chip Market Product Type Outlook** ### **Gene Chip Market Application Outlook** ### **Gene Chip Market End User Outlook** ### **Gene Chip Market Regional Outlook** ## Market Drivers ### Rising Investment in Genomic Research Investment in genomic research is a key driver for the Gene Chip Market. Governments and private entities are allocating substantial funds to genomics, recognizing its potential to revolutionize healthcare. This influx of capital is fostering innovation and development within the gene chip sector. For instance, funding initiatives aimed at mapping human genomes and understanding complex diseases are likely to propel the demand for advanced gene chips. The market is anticipated to benefit from these investments, with growth rates potentially exceeding 12% annually as research institutions and biotech companies seek to leverage gene chips for groundbreaking discoveries. ### Regulatory Support and Standardization Regulatory support and standardization are emerging as vital drivers for the Gene Chip Market. As the demand for gene chips increases, regulatory bodies are establishing guidelines to ensure the safety and efficacy of these products. This regulatory framework is essential for fostering consumer confidence and encouraging market growth. Moreover, standardization efforts are likely to streamline the development process, making it easier for manufacturers to bring innovative gene chips to market. The Gene Chip Market is expected to benefit from these regulatory advancements, potentially leading to a more robust and competitive landscape. ### Growing Demand for Diagnostic Applications The Gene Chip Market is experiencing a growing demand for diagnostic applications, particularly in the fields of oncology and infectious diseases. Gene chips are increasingly utilized for the early detection and monitoring of diseases, which is crucial for effective treatment strategies. The market for diagnostic applications is projected to expand significantly, with estimates suggesting a growth rate of around 9% over the next few years. As healthcare providers seek more efficient diagnostic tools, the Gene Chip Market is likely to see heightened interest and investment in developing specialized gene chips tailored for various diseases. ### Increasing Adoption of Personalized Medicine The Gene Chip Market is witnessing a surge in the adoption of personalized medicine, which tailors medical treatment to individual characteristics. This trend is driven by the growing understanding of genetic variations and their impact on drug response. Gene chips play a pivotal role in this paradigm shift by enabling the analysis of genetic profiles, thus facilitating targeted therapies. The market for personalized medicine is expected to reach substantial figures, with projections indicating a valuation exceeding several billion dollars in the near future. As healthcare systems increasingly embrace personalized approaches, the Gene Chip Market is poised for significant growth. ### Technological Advancements in Gene Chip Market The Gene Chip Market is experiencing rapid technological advancements that enhance the capabilities of gene chips. Innovations such as next-generation sequencing and microarray technologies are driving the development of more efficient and accurate gene chips. These advancements allow for higher throughput and improved sensitivity, which are crucial for applications in genomics and personalized medicine. The market is projected to grow significantly, with estimates suggesting a compound annual growth rate of over 10% in the coming years. As technology continues to evolve, the Gene Chip Market is likely to witness the introduction of novel applications, further expanding its reach in research and clinical diagnostics. ## Future Outlook The Gene Chip Market is projected to grow at a 7.17% CAGR from 2025 to 2035, driven by advancements in genomics, personalized medicine, and increasing demand for high-throughput screening. **New opportunities:** - Development of integrated bioinformatics platforms for data analysis. - Expansion into emerging markets with tailored gene chip solutions. - Partnerships with pharmaceutical companies for drug discovery applications. By 2035, the Gene Chip Market is expected to be robust, driven by innovation and strategic collaborations. ## Segment Insights ### By Type: DNA Microarrays (Largest) vs. RNA Microarrays (Fastest-Growing) The Gene Chip Market exhibits a diverse landscape with distinct segments contributing to its overall dynamics. Among these, DNA Microarrays hold the largest market share, owing to their extensive applications in genomic research and diagnostics. In contrast, RNA Microarrays, while smaller in share, are rapidly gaining traction due to the increasing importance of transcriptomics in understanding gene expression and regulation. DNA Microarrays (Dominant) vs. RNA Microarrays (Emerging) DNA Microarrays are the dominant force in the Gene Chip Market, primarily due to their robustness and versatility in various applications, including disease diagnosis and genetic analysis. They are widely utilized in research settings, facilitating high-throughput analysis of gene expression. On the other hand, RNA Microarrays are emerging as a vital tool for studying gene expression levels, providing insights into the regulatory roles of RNA molecules. Their growing importance is driven by advancements in personalized medicine and increasing demand for precise biomarker discovery, making them a critical component of the market's evolution. ### By Application: Medical Diagnostics (Largest) vs. Pharmaceutical Research (Fastest-Growing) The Gene Chip Market showcases a diverse range of applications, with Medical Diagnostics claiming the largest market share. This segment benefits significantly from increasing demands for precision medicine, personalized treatment options, and the rising prevalence of genetic disorders, thus establishing itself as the dominant force in the market. In contrast, Pharmaceutical Research is emerging rapidly, driven by the growing need for innovative drug development processes and the integration of genomic information into therapeutic strategies. This segment is witnessing increased investments and collaborations, marking it as a critical area for future expansion. Medical Diagnostics (Dominant) vs. Pharmaceutical Research (Emerging) Medical Diagnostics is the dominant application segment within the Gene Chip Market, characterized by its crucial role in disease detection and monitoring. The rapid advancements in genomic technologies have allowed for the development of highly accurate diagnostic tools that facilitate early disease detection, significantly impacting treatment outcomes. In comparison, Pharmaceutical Research is classified as an emerging segment, experiencing rapid growth as it integrates gene chip technologies into drug discovery. This segment is fueled by increasing collaborations between biotechnology firms and research institutions, emphasizing the need for targeted therapies. Both segments are vital, serving distinct yet interconnected roles in improving healthcare outcomes. ### By End User: Pharmaceutical and Biotechnology Companies (Largest) vs. Clinical Laboratories (Fastest-Growing) The Gene Chip Market is significantly shaped by various end users, with Pharmaceutical and Biotechnology Companies taking the lead in market share. This segment has strengthened its position due to increasing investments in drug discovery and personalized medicine, making it the most substantial contributor to market dynamics. On the other hand, Clinical Laboratories are rapidly expanding their role in this market, driven by an increasing demand for genomic testing and precision health. As these laboratories integrate more advanced technologies into their diagnostic processes, their market share continues to grow. Growth trends in the Gene Chip Market are primarily influenced by the rising emphasis on precision medicine and personalized healthcare. Technological advancements are enabling more efficient and accurate genomic analyses. Furthermore, the collaboration between Academic and Research Institutions and industry players is facilitating innovation and expanding the application range of gene chips. This ecosystem not only enhances research capabilities but also accelerates the commercialization of new diagnostics, leading to a promising growth outlook for all segments involved. Pharmaceutical and Biotechnology Companies (Dominant) vs. Clinical Laboratories (Emerging) Pharmaceutical and Biotechnology Companies dominate the Gene Chip Market, leveraging advanced genomic technologies to enhance drug discovery processes. Their focus on personalized medicine has significantly propelled this segment, as these companies utilize gene chips for identifying genetic variations and developing targeted therapies. Conversely, Clinical Laboratories represent the emerging segment within the market, primarily driven by the increasing adoption of genomic testing. These laboratories are progressively incorporating gene chips into their diagnostic practices, enhancing their ability to provide precise health assessments. The seamless integration of cutting-edge technologies in both segments is shaping future trends, making them pivotal players in the ongoing evolution of the Gene Chip Market. ## Regional Market Share Analysis ### North America : Innovation and Leadership Hub North America is the largest market for gene chips, holding approximately 45% of the global share. The region benefits from advanced research facilities, significant investments in biotechnology, and a strong regulatory framework that encourages innovation. The demand for personalized medicine and genomic research is driving growth, with increasing applications in diagnostics and therapeutics. Regulatory support from agencies like the FDA further catalyzes market expansion. The United States is the leading country in this market, home to major players such as Illumina, Thermo Fisher Scientific, and Affymetrix. The competitive landscape is characterized by rapid technological advancements and collaborations between academia and industry. Canada also plays a significant role, contributing to research and development initiatives. The presence of key players ensures a robust supply chain and innovation pipeline. ### Europe : Emerging Market with Potential Europe is the second-largest market for gene chips, accounting for approximately 30% of the global market share. The region is witnessing a surge in demand driven by advancements in genomics and personalized medicine. Regulatory frameworks, such as the EU's General Data Protection Regulation (GDPR), are shaping the landscape, ensuring ethical use of genetic data while promoting innovation. Countries like Germany and the UK are at the forefront of this growth, supported by government initiatives and funding. Germany leads the European market, with a strong presence of key players like Qiagen and Roche. The UK follows closely, emphasizing research and development in genomics. The competitive landscape is marked by collaborations between biotech firms and academic institutions, fostering innovation. The European market is also characterized by a growing focus on sustainable practices and ethical considerations in genetic research. ### Asia-Pacific : Rapid Growth and Adoption Asia-Pacific is rapidly emerging as a significant player in the gene chip market, holding approximately 20% of the global share. The region is driven by increasing investments in healthcare and biotechnology, coupled with a growing emphasis on personalized medicine. Countries like China and Japan are leading this growth, supported by government initiatives aimed at enhancing research capabilities and technological advancements. The regulatory environment is evolving, promoting innovation while ensuring safety and efficacy. China is the largest market in the region, with substantial investments in genomic research and development. Japan follows closely, with a strong focus on technological advancements in gene chips. The competitive landscape is characterized by a mix of local and international players, fostering a dynamic environment for innovation. The presence of key players like Agilent Technologies and Bio-Rad Laboratories further strengthens the market position in this region. ### Middle East and Africa : Emerging Market with Challenges The Middle East and Africa region is gradually emerging in the gene chip market, holding approximately 5% of the global share. The growth is driven by increasing healthcare investments and a rising focus on genomics and personalized medicine. However, challenges such as limited infrastructure and regulatory hurdles persist. Countries like South Africa and the UAE are making strides in biotechnology, supported by government initiatives aimed at enhancing research capabilities and fostering innovation. South Africa is the leading country in this region, with a growing emphasis on genomic research and development. The UAE is also emerging as a hub for biotechnology, attracting investments and fostering collaborations. The competitive landscape is still developing, with a mix of local and international players. The presence of key players is limited, but the potential for growth is significant as the region continues to invest in healthcare and biotechnology. ## Competitive Benchmarking Major players in the Gene Chip Market are constantly engaging in strategic collaborations, acquisitions, and partnerships to expand their market presence and strengthen their competitive position. Leading Gene Chip Market players are investing heavily in research and development activities to introduce technologically advanced products and solutions.The Gene Chip Market is expected to witness significant growth in the coming years, driven by the increasing demand for [personalized medicine](https://www.marketresearchfuture.com/reports/personalized-medicine-market-2937), advancements in genomics technologies, and the rising prevalence of chronic diseases. The competitive landscape of the Gene Chip Market is characterized by a mix of established and emerging players, each with their unique strengths and focus areas.Among the leading players in the Gene Chip Market, [Thermo Fisher Scientific](https://www.thermofisher.com/in/en/home/life-science/microarray-analysis/microarray-analysis-instruments-software-services/microarray-analysis-software/affymetrix-genechip-command-console-software.html) holds a dominant position with a comprehensive portfolio of products and services.The company offers a wide range of gene chips for various applications, including gene expression analysis, [genotyping](https://www.marketresearchfuture.com/reports/genotyping-market-6635), and copy number variation analysis. Thermo Fisher Scientific also provides supporting instruments, software, and reagents, enabling end-to-end solutions for gene chip-based research.Another major player in the Gene Chip Market is Illumina, Inc., known for its innovative sequencing technologies. Illumina offers a range of gene chips designed for applications such as targeted sequencing, whole-genome sequencing, and single-cell analysis. The company's focus on developing high-throughput and cost-effective sequencing solutions has contributed to its strong position in the market.A notable competitor in the Gene Chip Market is Affymetrix, Inc., a subsidiary of Thermo Fisher Scientific. Affymetrix offers a portfolio of gene chips for gene expression analysis and genotyping.The company's gene chips are known for their high sensitivity and specificity, making them well-suited for applications in clinical diagnostics and research. Affymetrix also provides a range of supporting software and services, enabling comprehensive data analysis and interpretation. ## Recent News & Developments The increasing adoption of Gene Chip Market technology in personalized medicine, drug discovery, and genetic research drives market growth. Key industry developments include Illumina's launch of the NovaSeq X Series, offering faster sequencing speeds, and Thermo Fisher Scientific's acquisition of Affymetrix, expanding its portfolio of Gene Chip Market solutions. Growing government funding for genomics research and the rising prevalence of chronic diseases further contribute to market expansion. ## Report Scope | MARKET SIZE 2024 | 1.97(USD Billion) | | --- | --- | | MARKET SIZE 2025 | 2.111(USD Billion) | | MARKET SIZE 2035 | 4.219(USD Billion) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 7.17% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Billion | | Key Companies Profiled | Affymetrix (US), Illumina (US), Thermo Fisher Scientific (US), Agilent Technologies (US), Roche (CH), Bio-Rad Laboratories (US), Qiagen (DE), PerkinElmer (US), Arrayit Corporation (US) | | Segments Covered | Product Type, Application, End User, Regional | | Key Market Opportunities | Advancements in personalized medicine drive demand for innovative solutions in the Gene Chip Market. | | Key Market Dynamics | Technological advancements and regulatory changes drive innovation and competition in the Gene Chip Market. | | Countries Covered | North America, Europe, APAC, South America, MEA | ## Frequently Asked Questions **Q: What is the current valuation of the Gene Chip Market as of 2024?** A: The Gene Chip Market was valued at 1.97 USD Billion in 2024. **Q: What is the projected market size for the Gene Chip Market in 2035?** A: The market is projected to reach 4.219 USD Billion by 2035. **Q: What is the expected CAGR for the Gene Chip Market during the forecast period 2025 - 2035?** A: The expected CAGR for the Gene Chip Market during 2025 - 2035 is 7.17%. **Q: Which companies are considered key players in the Gene Chip Market?** A: Key players include Affymetrix, Illumina, Thermo Fisher Scientific, and Agilent Technologies. **Q: What are the main types of microarrays in the Gene Chip Market?** A: The main types include DNA Microarrays, RNA Microarrays, Protein Microarrays, and Other Microarrays. **Q: How did the valuation of DNA Microarrays change from 2024 to 2035?** A: The valuation of DNA Microarrays increased from 0.79 USD Billion in 2024 to a projected 1.68 USD Billion in 2035. **Q: What applications are driving growth in the Gene Chip Market?** A: Key applications include Medical Diagnostics, Pharmaceutical Research, and Academic Research. **Q: What is the projected growth for Medical Diagnostics in the Gene Chip Market by 2035?** A: Medical Diagnostics is expected to grow from 0.79 USD Billion in 2024 to 1.67 USD Billion by 2035. **Q: Which end users are contributing to the Gene Chip Market's expansion?** A: End users include Pharmaceutical and Biotechnology Companies, Academic and Research Institutions, and Clinical Laboratories. **Q: What is the expected valuation for Clinical Laboratories in 2035?** A: The expected valuation for Clinical Laboratories is projected to rise from 0.25 USD Billion in 2024 to 0.53 USD Billion by 2035. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/gene-chip-market-29562*